As of 2025-05-06, the EV/EBITDA ratio of Zosano Pharma Corp (ZSAN) is 0.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ZSAN's latest enterprise value is -9.06 mil USD. ZSAN's TTM EBITDA according to its financial statements is -28.51 mil USD. Dividing these 2 quantities gives us the above ZSAN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.8x - 24.1x | 21.6x |
| Forward P/E multiples | 23.3x - 26.0x | 24.4x |
| Fair Price | (133.39) - (137.70) | (131.56) |
| Upside | -24023.0% - -24795.2% | -23694.3% |
| Date | EV/EBITDA |